Biotechnology Assets, S.A. (BME:BST)
0.2100
+0.0100 (5.00%)
Jul 17, 2026, 5:35 PM CET
Biotechnology Assets Employees
Biotechnology Assets had 26 employees as of December 31, 2025. The number of employees decreased by 8 or -23.53% compared to the previous year.
Employees
26
Change
-8
Growth
-23.53%
Revenue / Employee
€131,986
Profits / Employee
€73,695
Market Cap
15.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 26 | -8 | -23.53% |
| Jun 30, 2025 | 30 | - | - |
| Dec 31, 2024 | 34 | -3 | -8.11% |
| Dec 31, 2023 | 37 | 3 | 8.82% |
| Dec 31, 2022 | 34 | 1 | 3.03% |
| Dec 31, 2021 | 33 | 4 | 13.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Grifols | 25,000 |
| Faes Farma | 2,681 |
| Almirall | 2,108 |
| Laboratorios Farmaceuticos Rovi | 2,045 |
| Laboratorio Reig Jofre | 1,400 |
| Prim, S.A. | 984 |
| Atrys Health | 758 |
| Labiana Health | 394 |